Santa Clara, CAAt least 70 complaints have been filed against Ozempic, Wegovy, Saxenda, and Trulicity claiming that GLP-1 receptor agonists triggered irreversible eye damage called non-arteritic anterior ischemic optic neuropathy (NAION). Legal... Read more »
Ozempic lawsuits allege Novo Nordisk failed to warn consumers that its diabetes and weight loss drug carries dangerous side effects, including severe gastroparesis (known as stomach paralysis), gastroenteritis, gallbladder disease and other... Read more »
Todd Girshon discusses the implications of New York City enacting legislation banning employment discrimination based on weight or height, and the requirement to protect workers from workplace harassment based on those qualities... Read more »
The New York City ordinance banning discrimination in employment, housing, and public accommodations on the basis of an individual’s height and weight is set to go into effect on November 22, 2023.... Read more »